Literature DB >> 33383814

Evaluation in Swine of a Recombinant Georgia 2010 African Swine Fever Virus Lacking the I8L Gene.

Elizabeth Vuono1,2, Elizabeth Ramirez-Medina1,3, Sarah Pruitt1, Ayushi Rai1,4, Ediane Silva1,5, Nallely Espinoza1, James Zhu1, Lauro Velazquez-Salinas1,5, Douglas P Gladue1, Manuel V Borca1.   

Abstract

African swine fever virus (ASFV) is the causative agent of African swine fever, a disease currently causing significant economic losses in Europe and Asia. Specifically, the highly virulent ASFV strain Georgia 2010 (ASFV-G) is producing disease outbreaks in this large geographical region. The ASFV genome encodes for over 150 genes, most of which are still not experimentally characterized. I8L is a highly conserved gene that has not been studied beyond its initial description as a virus ORF. Transcriptional analysis of swine macrophages infected with ASFV-G demonstrated that the I8L gene is transcribed early during the virus replication cycle. To assess the importance of I8L during ASFV-G replication in vitro and in vivo, as well as its role in virus virulence in domestic swine, we developed a recombinant virus lacking the I8L gene (ASFV-G-ΔI8L). Replication of ASFV-G-ΔI8L was similar to parental ASFV-G replication in primary swine macrophage cultures, suggesting that the I8L gene is not essential for ASFV-G replication in vitro. Similarly, replication of ASFV-G-ΔI8L in swine intramuscularly inoculated with 102 HAD50 displayed replication kinetics similar to ASFV-G. In addition, animals inoculated with ASFV-G-ΔI8L presented with a clinical disease indistinguishable from that induced by the same dose of the virulent parental ASFV-G isolate. We conclude that deletion of the I8L gene from ASFV-G does not affect virus replication in vitro or in vivo, nor changes the disease outcome in swine.

Entities:  

Keywords:  ASF; ASFV; African swine fever; I8L gene; recombinant ASFV; virus virulence

Year:  2020        PMID: 33383814     DOI: 10.3390/v13010039

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  6 in total

1.  Deletion of the A137R Gene from the Pandemic Strain of African Swine Fever Virus Attenuates the Strain and Offers Protection against the Virulent Pandemic Virus.

Authors:  Douglas P Gladue; Elizabeth Ramirez-Medina; Elizabeth Vuono; Ediane Silva; Ayushi Rai; Sarah Pruitt; Nallely Espinoza; Lauro Velazquez-Salinas; Manuel V Borca
Journal:  J Virol       Date:  2021-08-18       Impact factor: 5.103

Review 2.  Recombinant ASF Live Attenuated Virus Strains as Experimental Vaccine Candidates.

Authors:  Douglas P Gladue; Manuel V Borca
Journal:  Viruses       Date:  2022-04-23       Impact factor: 5.818

3.  African Swine Fever Virus and Host Response: Transcriptome Profiling of the Georgia 2007/1 Strain and Porcine Macrophages.

Authors:  Gwenny Cackett; Raquel Portugal; Dorota Matelska; Linda Dixon; Finn Werner
Journal:  J Virol       Date:  2022-01-12       Impact factor: 5.103

4.  ASFV Gene A151R Is Involved in the Process of Virulence in Domestic Swine.

Authors:  Elizabeth Ramirez-Medina; Elizabeth Vuono; Sarah Pruitt; Ayushi Rai; Nallely Espinoza; Alyssa Valladares; Edward Spinard; Ediane Silva; Lauro Velazquez-Salinas; Douglas P Gladue; Manuel V Borca
Journal:  Viruses       Date:  2022-08-21       Impact factor: 5.818

5.  Evaluation of the Function of the ASFV KP177R Gene, Encoding for Structural Protein p22, in the Process of Virus Replication and in Swine Virulence.

Authors:  Elizabeth A Vuono; Elizabeth Ramirez-Medina; Sarah Pruitt; Ayushi Rai; Nallely Espinoza; Lauro Velazquez-Salinas; Douglas P Gladue; Manuel V Borca
Journal:  Viruses       Date:  2021-05-26       Impact factor: 5.048

6.  Evaluation of an ASFV RNA Helicase Gene A859L for Virus Replication and Swine Virulence.

Authors:  Elizabeth Ramirez-Medina; Elizabeth A Vuono; Sarah Pruitt; Ayushi Rai; Nallely Espinoza; Lauro Velazquez-Salinas; Douglas P Gladue; Manuel V Borca
Journal:  Viruses       Date:  2021-12-21       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.